Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
9,457 total articles
Atomera Incorporated (NASDAQ:ATOM) saw its stock fall 15% on Monday after announcing a $25 million registered direct offering to institutional investors. The company agreed to sell 5,000,000 shares at $5.00 per share under a securities purchase agreement, with the transaction expected to close on or about February 24, 2026, subject to customary clo…
Gilead Sciences agreed to acquire Arcellx for $115 in cash per share plus a $5 contingent value right, an agreement that values Arcellx at about $7.8 billion. The transaction, approved by both boards and expected to close in Q2 2026 subject to customary conditions, consolidates Gilead's control of anito-cel, an investigational BCMA-directed CAR T t…
Citi told clients that fourth-quarter results and steady consensus estimates underpin its optimistic outlook for 2026. Analyst Scott Chronert reiterated that the firm "maintains a constructive fundamental outlook for 2026," citing positive Q4 2025 earnings trends, accelerating sales across market caps and an above-consensus S&P 500 earnings project…
Shares of Shutterstock and Getty Images rose after the U.S. Department of Justice concluded its antitrust review and the Hart-Scott-Rodino waiting period expired without conditions, marking a key regulatory milestone for the proposed merger of equals. The companies say the deal should unlock synergies, but a Phase 2 review by the U.K. Competition a…
Two real estate investment trusts, Innovative Industrial Properties (IIPR) and Arbor Realty Trust (ABR), are attracting attention for their current yields north of 16% and multi-year payout characteristics heading into 2026. WarrenAI highlights IIPR for its consistent dividend growth and a nine-year payment streak, while ABR is noted for its high c…
UBS reduced its recommendation on Swiss regional bank Valiant Holding AG from buy to neutral while nudging its 12-month price target up to CHF168 from CHF155. The brokerage argued that the stock's rally and announced capital returns have largely captured the upside potential, leaving limited expected outperformance versus UBS's market return assump…
Warner Bros. Discovery shares gained on Monday after reports indicated that Paramount Skydance, led by David Ellison, is poised to submit an enhanced takeover proposal of $32 per share. The company faces a deadline to file a best and final offer within a weeklong window granted by Warner Bros. Discovery's board, a period that ends at 11:59 p.m. ET …
CenterPoint Energy shares fell 2.7% to $41.85 in premarket trading after the company announced a private placement of $550 million in convertible bonds due May 2029. The Houston-based utility said net proceeds will be used for general corporate purposes, including repaying commercial paper and other debt. The move follows a record high close of $43…
Gilead Sciences agreed to acquire Arcellx for up to $7.8 billion in cash, paying $115 per share - a 79% premium to Arcellx's last close - to strengthen its cancer-treatment offerings. The deal links Gilead, through its Kite Pharma unit, to the development of anito-cel, an investigational CAR-T therapy for multiple myeloma that is under FDA review w…
Deutsche Bank raised price targets across several Spanish banks and upgraded ratings for Bankinter, Banco Sabadell and CaixaBank after analysts observed stronger-than-expected net interest income resilience in 2025, diversified fee income and tighter cost control. The bank expects net interest income to resume growth in 2026 and projects returns on…
Celsius Holdings shares climbed after management disclosed larger-than-expected shelf space increases for both Alani Nu and the Celsius brand at a recent investor conference. TD Cowen reiterated a Buy rating and highlighted the quantified distribution gains, while projecting above-consensus sales and EBITDA for coming years.
Evercore ISI says the recent, indiscriminate selloff of AI-exposed stocks has opened chances to pick firms with resilient strategies. The firm argues that companies investing early in orchestration, secure enterprise guardrails and agentic execution across siloed data will be best placed as AI adoption broadens, and it names eight stocks it views a…
Jefferies revisited its application software coverage after sizeable underperformance across the group and, using a new AI Risk Matrix alongside company-specific fundamentals, highlighted four stocks it prefers for the AI transition: Intuit, Procore Technologies, Atlassian and Salesforce. The firm shifted several other app names to Hold because of …
Verisk Analytics said it entered into accelerated share repurchase (ASR) agreements totaling $1.5 billion with HSBC Bank USA, N.A. and Wells Fargo Bank, N.A. The stock rose 1.5% on the news. The transactions include an initial delivery of about 7.0 million shares and are expected to settle no later than the company’s third fiscal quarter ending Sep…
UBS updated its geopolitical framework and identified a group of European oil companies it believes are well positioned to benefit if an Iran-related risk premium pushes crude prices higher. The bank sees upstream-exposed producers and certain oil services and chemicals businesses as likely near-term beneficiaries, while integrated majors with disc…
Veris Residential will be taken private in a $3.4 billion cash transaction led by an investor consortium headed by Affinius Capital in partnership with Vista Hill Partners. The $19.00 per-share offer represents a 13% premium to the most recent close and follows a strategic review supported by J.P. Morgan and Morgan Stanley.
RBC Capital Markets upgraded Banco Santander to outperform from sector perform and raised its price target to €12.25 from €8.50 ahead of the bank’s Investor Day on Feb. 25. The brokerage’s revised view rests on a projected improvement in return on tangible equity, a planned self-help cost reduction, and substantial shareholder distributions under a…
U.S. stock futures traded lower Monday as investors weighed renewed trade uncertainty following a Supreme Court decision on emergency tariffs. Several notable premarket movers included a steep decline for Novo Nordisk after a failed obesity drug trial, gains for Eli Lilly and Domino’s Pizza, and a large rally in Arcellx after a takeover agreement w…
Finnish quantum computing company IQM has agreed to merge with special purpose acquisition company Real Asset Acquisition Corp., a move that would bring the startup to the New York Stock Exchange with an initial equity valuation of $1.8 billion. The transaction, contingent on shareholder and regulatory approvals, is targeted to close around June, w…
Corning Inc. shares continued their advance after a late-week rally, supported by a UBS price-target increase and analyst commentary that rising hyperscaler capital expenditures should boost optical fiber demand within data centers. Long-term contracts with large cloud providers, including Meta, and planned capacity expansion underpin the bullish o…
Wells Fargo says the U.S. Supreme Court decision invalidating tariffs imposed under the International Emergency Economic Powers Act (IEEPA) is likely to prompt companies to accelerate inventory rebuilding. The brokerage is bullish on cyclicals, commodities and small-cap stocks, citing an expected re-stocking cycle, a modest lift to S&P 500 earnings…
RBC Capital’s U.S. equity strategy team says recent tariff developments do not change its longer-term constructive view on U.S. equities. Head of U.S. equity strategy research Lori Calvasina told clients that near- to intermediate-term effects range from "having little impact" to being "slightly positive," and that companies have demonstrated the a…
Merck announced a reorganization that splits its human-health operations into two businesses, isolating its cancer franchise anchored by Keytruda from its non-oncology medicines. The move comes as Keytruda faces an impending loss of patent protection after generating nearly half of Merck's revenue in 2025 and more than $30 billion in sales that yea…
Three former colleagues who previously worked together at Farrer and received initial backing from Millennium Management in 2024 are launching separate commodity-focused hedge funds targeting a combined $1.4 billion. Les Finemore and Al Fullerton have formed Moreton Capital Partners, aiming for $1 billion with an AI-enhanced quantitative approach, …
Novo Nordisk fell sharply after its next-generation obesity medicine CagriSema failed to demonstrate parity with Eli Lilly’s tirzepatide in a head-to-head trial. The share price drop wiped out the remaining market gains from Wegovy’s launch and pushed the stock to its lowest levels since mid-2021, reigniting concerns about competition and future re…
